1569. In Vitro Activity of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and Pseudomonas aeruginosa Collected from Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2015-2018

BACKGROUND: Avibactam (AVI) is a β-lactamase inhibitor with potent inhibitory activity against Class A, Class C, and some Class D serine β-lactamases. The combination of ceftazidime (CAZ) with AVI has been approved in Europe and in the United States for several indications. This study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazmierczak, Krystyna, Lob, Sibylle, Stone, Greg, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778253/
http://dx.doi.org/10.1093/ofid/ofaa439.1749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778253/
http://dx.doi.org/10.1093/ofid/ofaa439.1749

Ejemplares similares